Difference between revisions of "Stanisław Burzyński"

From Psiram
Jump to navigation Jump to search
Line 3: Line 3:
  
 
== Legal Issues ==
 
== Legal Issues ==
In 1993, Burzynski was brought to court in Texas for treating patients with a therapy not approved by the Food and Drug Administration (FDA) and for selling antineoplastons in interstate commerce.<ref name=opinion />[http://www.3rdcoa.courts.state.tx.us/opinions/HTMLopinion.asp?OpinionID=847 Texas State Board of Medical Examiners, Appellant v. Stanislaw R. Burzynski, M.D., Ph.D., Appellee] Court judgement</ref><ref name="openjurist1987" /> In 1998 the Texas Attorney General, Dan Morales, placed limits on his advertising of antineoplastons<ref>{{cite web | author = Texas Attorney General's Office | title = Limits Placed on Burzynski's Cancer Treatment | url = http://www.quackwatch.org/04ConsumerEducation/News/burzynski.html | date = 1998-02-10 | accessdate = 2007-05-10|format=courtesy copy}}</ref> and ordered him to cease and desist selling his products without FDA supervised clinical trials.<ref name=1994judgement/> Burzynski appealed the limitations on his advertising on the grounds of free speech, but the appeal court upheld the decision, stating that "Burzynski's commercial speech does not concern a lawful activity."<ref name=opinion/> Burzynski was also found guilty of fraud in 1994, as he claimed reimbursement from a [[health insurer]] for a cancer treatment administered illegally.<ref name=1994judgement>[ftp://www.ca5.uscourts.gov/pub/93/93-02071.CV0.wpd.pdf No. 93-2071] July 28, 1994. United States Court of Appeals, Fifth Circuit summary judgment.</ref>
+
In 1993, Burzynski was brought to court in Texas for treating patients with a therapy not approved by the Food and Drug Administration (FDA) and for selling antineoplastons in interstate commerce.<ref name=opinion />[http://www.3rdcoa.courts.state.tx.us/opinions/HTMLopinion.asp?OpinionID=847 Texas State Board of Medical Examiners, Appellant v. Stanislaw R. Burzynski, M.D., Ph.D., Appellee] Court judgement</ref><ref name="openjurist1987" /> In 1998 the Texas Attorney General, Dan Morales, placed limits on his advertising of antineoplastons</ref><ref>{{cite web | author = Texas Attorney General's Office | title = Limits Placed on Burzynski's Cancer Treatment | url = http://www.quackwatch.org/04ConsumerEducation/News/burzynski.html | date = 1998-02-10 | accessdate = 2007-05-10|format=courtesy copy}}</ref> and ordered him to cease and desist selling his products without FDA supervised clinical trials.<ref name=1994judgement/> Burzynski appealed the limitations on his advertising on the grounds of free speech, but the appeal court upheld the decision, stating that "Burzynski's commercial speech does not concern a lawful activity."<ref name=opinion/> Burzynski was also found guilty of fraud in 1994, as he claimed reimbursement from a [[health insurer]] for a cancer treatment administered illegally.<ref name=1994judgement>[ftp://www.ca5.uscourts.gov/pub/93/93-02071.CV0.wpd.pdf No. 93-2071] July 28, 1994. United States Court of Appeals, Fifth Circuit summary judgment.</ref>
 
Burzynski will have a hearing with the Texas Medical Board in April 2012. The board might well revoke his approbation.
 
Burzynski will have a hearing with the Texas Medical Board in April 2012. The board might well revoke his approbation.
  

Revision as of 05:50, 17 December 2014

Stanisław Burzyński

Stanislaw Rajmund Burzynski (born January 23, 1943 in Lublin, Poland) is a biochemist and a physician. He is the founder, president, and chairman of Burzynski Research Institute Inc. , based in Houston and Stafford, Texas. Since December 1976, Burzynski administered peptides and their metabolites, which he calls antineoplastons, as a treatment against cancer.

Legal Issues

In 1993, Burzynski was brought to court in Texas for treating patients with a therapy not approved by the Food and Drug Administration (FDA) and for selling antineoplastons in interstate commerce.[1]Texas State Board of Medical Examiners, Appellant v. Stanislaw R. Burzynski, M.D., Ph.D., Appellee Court judgement</ref>[2] In 1998 the Texas Attorney General, Dan Morales, placed limits on his advertising of antineoplastons</ref>[3] and ordered him to cease and desist selling his products without FDA supervised clinical trials.[4] Burzynski appealed the limitations on his advertising on the grounds of free speech, but the appeal court upheld the decision, stating that "Burzynski's commercial speech does not concern a lawful activity."[1] Burzynski was also found guilty of fraud in 1994, as he claimed reimbursement from a health insurer for a cancer treatment administered illegally.[4] Burzynski will have a hearing with the Texas Medical Board in April 2012. The board might well revoke his approbation.

Main Article: Antineoplaston

Links

References

  1. 1.0 1.1 Cite error: Invalid <ref> tag; no text was provided for refs named opinion
  2. Cite error: Invalid <ref> tag; no text was provided for refs named openjurist1987
  3. Template:Cite web
  4. 4.0 4.1 No. 93-2071 July 28, 1994. United States Court of Appeals, Fifth Circuit summary judgment.